Efficacy and Safety of Odronextamab Monotherapy in Patients (Pts) with Diffuse Large B-Cell Lymphoma (DLBCL) Progressing after CAR T-Cell Therapy: Primary Analysis from the ELM-1 StudyMatthew J. Matasar, Jennifer L. Crombie, Jon Arnason et al.|Blood|2024Cited by 2